PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,981 | -1.9% | 16,935 | 0.0% | 0.00% | – |
| Q2 2023 | $106,013 | +51.0% | 16,935 | +15.1% | 0.00% | – |
| Q1 2023 | $70,191 | -45.2% | 14,715 | 0.0% | 0.00% | – |
| Q4 2022 | $128,021 | -27.1% | 14,715 | -0.2% | 0.00% | – |
| Q3 2022 | $175,501 | -18.5% | 14,748 | -2.5% | 0.00% | – |
| Q2 2022 | $215,460 | -11.5% | 15,120 | +29.3% | 0.00% | – |
| Q1 2022 | $243,490 | -26.9% | 11,695 | -18.9% | 0.00% | – |
| Q4 2021 | $333,000 | -18.8% | 14,413 | +4.8% | 0.00% | – |
| Q3 2021 | $410,000 | -18.2% | 13,750 | -6.3% | 0.00% | – |
| Q2 2021 | $501,000 | +100.4% | 14,674 | +92.9% | 0.00% | – |
| Q1 2021 | $250,000 | -48.2% | 7,609 | -3.1% | 0.00% | – |
| Q4 2020 | $483,000 | – | 7,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |